Breaking News: Vaccine developer with Boston HQ acquired for $1.25B

The German company that helped develop Pfizer's Covid-19 vaccine is acquiring a vaccine maker with its U.S. headquarters in Boston that sued it for intellectual property just a few years ago.

BREAKING NEWS Vaccine developer with Boston HQ acquired for $1.25B The German company that helped develop Pfizer's Covid-19 vaccine is acquiring a vaccine maker with its U.S. headquarters in Boston that sued it for intellectual property just a few years ago. READ MORE RELATED NEWS Mass. fights off challengers to its life science dominance Vertex lays off Providence workers, consolidates offices Scorpion spinout debuts with $177M, Bicara doubles footprint Boston biotech led by Gary Glick pulls plug on IPO plans Wyss spinout launches organ-chip tech as FDA shies from animal tests View as Webpage   Unsubscribe | Manage Preferences   All rights reserved. ©  Boston Business Journal Email sent by Boston Business Journal 70 Franklin Street, 8th Floor Boston, MA 02110 USA Download the free app for breaking news alerts on your phone